Cite
HARVARD Citation
Glintborg, B. et al. (n.d.). OP0225 Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry. Annals of the rheumatic diseases. p. 142. [Online].